Physician profile
Grace W Rose
NPI 1275581944
$2,558.82
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $819 · 2020: $1,017 · 2021: $637 · 2022: $60.81 · 2023: $24.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $421.57 | 2019-2021 | |
| Lilly USA, LLC | $250.72 | 2019-2021 | |
| Pfizer INC. | $221.24 | 2019-2021 | |
| Amgen INC. | $204.32 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $196.73 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.13 | 2019-2021 | |
| Amarin Pharma, INC. | $118.28 | 2019-2021 | |
| Abbvie INC. | $102.99 | 2021-2022 | |
| Abbott Laboratories | $100.44 | 2019-2023 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $93.92 | 2020-2021 | |
| Astellas Pharma US INC | $91.53 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $75.33 | 2021 | |
| Allergan, INC. | $73.23 | 2020 | |
| Janssen Pharmaceuticals, INC | $60.00 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $47.69 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $40.79 | 2020-2021 | |
| Sanofi Pasteur INC. | $39.99 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.20 | 2019-2021 | |
| Therapeuticsmd, INC. | $36.29 | 2019 | |
| Eisai INC. | $31.09 | 2020-2021 | |
| Ibsa Pharma INC. | $30.84 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $22.68 | 2019-2020 | |
| Corcept Therapeutics | $21.47 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.71 | 2019 | |
| Nestle Healthcare Nutrition INC. | $15.61 | 2021 | |
| Gilead Sciences, INC. | $15.23 | 2019 | |
| Antares Pharma, INC. | $14.08 | 2019 | |
| Zealand Pharma US, INC. | $13.79 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $12.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.